Trial Profile

Evaluation of safety and efficacy of T1h (anti-CD6) as monotherapy and in combination with methotrexate in patients with rheumatoid arthritis

Status: Suspended

Phase of Trial: Phase I/II

Latest Information Update: 13 Oct 2020

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Itolizumab (Primary) ; Methotrexate
Indications Rheumatoid arthritis
Focus Adverse reactions; Therapeutic Use
Sponsors Center of Molecular Immunology

Most Recent Events

12 Dec 2013 Status changed from recruiting to suspended, as per Cuban Clinical Trial Registry record
13 Sep 2011 New trial record

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com